Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes

INTRODUCTION: Recent studies revealed N-glycosylation signatures of type 2 diabetes, inflammation and cardiovascular risk factors. Most people with diabetes use medication to reduce cardiovascular risk. The association of these medications with the plasma N-glycome is largely unknown. We investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sunny S, Naber, Annemieke, Dotz, Viktoria, Schoep, Emma, Memarian, Elham, Slieker, Roderick C, Elders, Petra J M, Vreeker, Gerda, Nicolardi, Simone, Wuhrer, Manfred, Sijbrands, Eric J G, Lieverse, Aloysius G, 't Hart, Leen M, van Hoek, Mandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333804/
https://www.ncbi.nlm.nih.gov/pubmed/32616483
http://dx.doi.org/10.1136/bmjdrc-2020-001230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333804/
https://www.ncbi.nlm.nih.gov/pubmed/32616483
http://dx.doi.org/10.1136/bmjdrc-2020-001230

Ejemplares similares